Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.170NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.23NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.506NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.6.8NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.438.3NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.27NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.30NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.188NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.39NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.357NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BP.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.177.46NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.2.3.21NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
A.6NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.530NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.1.17.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.2.75.8NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
CH.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.633NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
DD.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.136NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XAYNWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
DJ.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XAENWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.467NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.484NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.476NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
A.19NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
A.18NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.404NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
CV.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
DJ.1.3NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BQ.1.1.73NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
DW.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BR.5.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.2.75.3NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XAKNWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.501NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.226NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.546NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.194NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.429.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
P.1.9 (Gamma)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.25.1.1 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.203NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.157NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.176NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.3.4 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.391NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.393NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used